Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 0 % of short-term debt in 2025; threshold 65 %.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
METAGENICS EUROPE from Oostende, company number BE0867162578, closed financial year 2025 with a result of € 4.5 million after tax. Compared with financial year 2024, the result moved from € 6.6 million to € 4.5 million. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.
€ 5.6 million
▼ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 4.5 million
▼ 32% vs 2024
Profit after tax over the fiscal year.
€ 9,128
▼ 51% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 5.1 million paid out
More than the year’s profit went to the shareholders; reserves fell.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Profit after taxes | € -58,377 | € 3,339,834 | € 6,570,031 | € 4,486,597 | ▼ 32% |
| Equity | € 13,908,967 | € 13,598,801 | € 6,168,832 | € 5,555,429 | ▼ 10% |
| Total debts | € 20,235,107 | € 20,553,287 | € 21,316,383 | € 21,918,946 | ▲ 3% |
| Cash | € 9,962 | € 23,174 | € 18,686 | € 9,128 | ▼ 51% |
| Retained profit | € 3,231,363 | € 2,921,197 | € -4,508,772 | € 477,825 | ▲ € 5 million |
| Dividend | € 0 | € 3,650,000 | € 14,000,000 | € 5,100,000 | ▼ 64% |
| Balance sheet total | € 34,144,074 | € 34,152,087 | € 27,485,215 | € 27,474,375 |
Key figures of METAGENICS EUROPE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to METAGENICS EUROPE?
What happened at METAGENICS EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 4.5 million (▼ 32% vs 2024). Source: NBB ↗
- Stijn Oste became a director. NBB
- Paul Konney became a director. NBB
- New establishment in Oostende. KBO
- Start of the company according to the CBE. KBO
In short
From € 58,377 loss in 2022 to € 4.5 million profit in 2025.
Paid € 253 in corporate taxes since 2022.
Best year ever: 2024, with € 6.6 million profit.
Paid out € 22.8 million in dividends to the owners in total.
A new publication or filing at METAGENICS EUROPE? We notify you, reason included.
Follow METAGENICS EUROPEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind METAGENICS EUROPE are Stijn Oste and Paul Konney. It owns 100% of Metagenics Italia SRL, 100% of Bionutrics SA, 100% of Metagenics Netherlands BV and 100% of Metagenics Belgium BV itself.
Directors
According to the 2025 annual accounts
Stijn Oste
Director
since 2022
Paul Konney
Director
since 2016
Establishments
Establishment units
Physical locations of this company
Edward Vlietinckstraat 20
8400 Oostende
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0867.162.578
- VAT number
- BE 0867.162.578
- Registered office
- Edward Vlietinckstraat 20, 8400 Oostende
- Names & denominations
- METAGENICS EUROPE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 September 2004
- Peppol
- Not registered